Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Factors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Enrolling By InvitationNCT06873035
What this trial is testing

An Interventional Study of Infigratinib in Children With Hypochondroplasia

Who this might be right for
Hypochondroplasia
QED Therapeutics, a BridgeBio company 24
Large-scale testing (Phase 3)Study completedNCT02296125
What this trial is testing

AZD9291 Versus Gefitinib or Erlotinib in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer

Who this might be right for
Locally Advanced or Metastatic EGFR Sensitising Mutation Positive Non Small Cell Lung Cancer
AstraZeneca 674
Testing effectiveness (Phase 2)Active Not RecruitingNCT04946968
What this trial is testing

Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers

Who this might be right for
Advanced Solid TumoursNon-small Cell Lung CancerHead and Neck Squamous Cell Carcinoma
National Cancer Centre, Singapore 24
Testing effectiveness (Phase 2)Looking for participantsNCT07292168
What this trial is testing

A Phase 1b/2 Study of the Safety and Efficacy of the Monoclonal Antibody OM-RCA-01 in Patients With Metastatic Tumors Expressing Fibroblast Growth Factor Receptor 1

Who this might be right for
Renal Cell Carcinoma MetastaticProstate Cancer MetastaticNon-small Cell Lung Cancer Metastatic+2 more
Kidney Cancer Research Bureau 58
Not applicableStudy completedNCT03019250
What this trial is testing

A Trial of Enteral Colostrum on Clinical Outcomes in Critically Ill Patients

Who this might be right for
Critical IllnessInfection ComplicationMultiple Organ Dysfunction Syndrome
National Nutrition and Food Technology Institute 200
Not applicableStudy completedNCT03027050
What this trial is testing

T-PRF Provides Advantages on Periodontal Healing: A Split Mouth Clinical Study

Who this might be right for
PeriodontitisPeriodontal Attachment Loss
Ataturk University 33
Testing effectiveness (Phase 2)Study completedNCT00637091
What this trial is testing

Efficacy Analysis of Cetuximab Plus Irinotecan in Patients With Wild-type KRAS Without Regard to Epidermal Growth Factor Receptor (EGFR) Expressions

Who this might be right for
Advanced Colorectal Cancer
Asan Medical Center 40
Not applicableStudy completedNCT03927118
What this trial is testing

Effect of Dexamethasone Implant on Optic Disc

Who this might be right for
Glaucoma and Ocular HypertensionDiabetic Macular EdemaIntravenous Drug Usage+1 more
Bulent Ecevit University 43
Testing effectiveness (Phase 2)Looking for participantsNCT07058519
What this trial is testing

Osimertinib-based Adaptive Treatment Guided by ctDNA EGFRm+ Monitoring in NSCLC

Who this might be right for
Locally Advanced or Metastatic EGFRm Non-small Cell Lung Cancer (NSCLC)
Shanghai Chest Hospital 250
Post-approval studies (Phase 4)Study completedNCT02658734
What this trial is testing

Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer Who Have Received Prior Treatment With Trastuzumab and a Taxane

Who this might be right for
HER2 Positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer
Hoffmann-La Roche 70
Testing effectiveness (Phase 2)Study completedNCT06806319
What this trial is testing

Assessment of Growth Factors Levels Associated with Wound Healing After Soft Tissue Crown Lengthening

Who this might be right for
Gingival Overgrowth
Al-Azhar University 80
Not applicableStudy completedNCT02135367
What this trial is testing

Platelet-rich Plasma (PRP) vs Viscosupplementation for the Treatment of Early Knee Articular Degenerative Pathology

Who this might be right for
Knee ChondropathyKnee Early Osteoarthritis
Istituto Ortopedico Rizzoli 185
Large-scale testing (Phase 3)Active Not RecruitingNCT05840211
What this trial is testing

Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy

Who this might be right for
Locally Advanced or Unresectable Metastatic Breast CancerStage IV Breast Cancer
Gilead Sciences 654
Not applicableStudy completedNCT00539734
What this trial is testing

Changes in Retinal Function After Intravitreal Ranibizumab for Age-related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Prince of Songkla University 25
Early research (Phase 1)Study completedNCT01764828
What this trial is testing

BAY86-9766 Plus Gemcitabine Phase I Study in Asian

Who this might be right for
Neoplasms
Bayer 23
Post-approval studies (Phase 4)Study completedNCT01223612
What this trial is testing

Lucentis (Ranibizumab) in Diabetic Macular Oedema: a Treatment Evaluation

Who this might be right for
Diabetic Retinopathy
Moorfields Eye Hospital NHS Foundation Trust 37
Early research (Phase 1)Study completedNCT00457067
What this trial is testing

Injected Ranibizumab to Treat Macular Telangiectasia With New Blood Vessel Formation

Who this might be right for
Telangiectasia
National Eye Institute (NEI) 5
Testing effectiveness (Phase 2)Looking for participantsNCT05579366
What this trial is testing

Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)

Who this might be right for
High Grade Epithelial Ovarian CancerHigh Grade Serous Ovarian CancerPrimary Peritoneal Carcinoma+12 more
Genmab 884
Testing effectiveness (Phase 2)UnknownNCT01869166
What this trial is testing

Treatment of Chemotherapy Refractory EGFR(Epidermal Growth Factor Receptor) Positive Advanced Solid Tumors (CART-EGFR)

Who this might be right for
Advanced EGFR-positive Solid Tumors
Chinese PLA General Hospital 60
Very early researchStudy completedNCT00140556
What this trial is testing

Angiogenic and EGFR Blockade With Curative Chemoradiation for Advanced Head and Neck Cancer

Who this might be right for
Head and Neck CancerPharynx Cancer
David M. Brizel, MD 28
Next Page